Genovis 2010 Annual Report is Published
Genovis Annual Report for 2010 is made available In Swedish on the website www.genovis.com. The Annual Report will also be available in English on April 21, 2011.
For more information, please contact: Sarah Fredriksson, CEO, Genovis AB Tel: 46 46 10 12 35 firstname.lastname@example.org
Genovis develops and designs smart nanoparticles for preclinical imaging and diagnostics and also develops and sells tools for modification of antibodies. Genovis shares are listed on Nasdaq OMX First North and Thenberg & Kinde Fondkommission ( 46 (0)31 745 50 00) is the Company’s certified adviser.